Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma

Discovery Medicine

Volumn 15, Issue 81, 2013, Pages 93-100

  Chan, Chi Chao ^a   Sen, H Nida ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; EYE TUMOR; HUMAN; LYMPHOMA; NOMENCLATURE; PATHOLOGY;

ANIMALS; EYE NEOPLASMS; HUMANS; LYMPHOMA; TERMINOLOGY AS TOPIC;

EID: 84885944486     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Asencio-Duran M, Vallejo-Garcia JL, Pastora-Salvador N, Fonseca-Sandomingo A, Romano MR. Vitreous diagnosis in neoplastic diseases. Mediators Inflamm 2012:930704, 2012.
2. Cassoux N, Giron A, Bodaghi B, Tran TH, Baudet S, Davy F, Chan CC, Lehoang P, Merle-Beral H. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci 48(7):3253-3259, 2007.
3. Cassoux N, Merle-Beral H, Leblond V, Bodaghi B, Milea D, Gerber S, Fardeau C, Reux I, Xuan KH, Chan CC, Lehoang P. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm 8(4):243-250, 2000.
4. Cassoux N, Merle-Beral H, Lehoang P, Herbort C, Chan CC. Interleukin-10 and intraocular-central nervous system lymphoma. Ophthalmology 108(3):426-427, 2001.
5. Chan CC. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc 101:275-292, 2003.
6. Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol 13(6):411-418, 2002.
7. Chan CC, Gonzalez JA. Primary Intraocular Lymphoma. World Scientific Publishing Co. Pte. Ltd., New Jersey, USA, 2007.
8. Chan CC, Rubenstein JL, Coupland SE, Davis JL, Harbour JW, Johnston PB, Cassoux N, Touitou V, Smith JR, Batchelor TT, Pulido JS. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist 16(11):1589-1599, 2011.
9. Chan CC, Sauer TC. Ocular imaging in primary retinal lymphoma. Am J Ophthalmol 147(5):764-765, 2009.
10. Chan CC, Shen D, Hackett JJ, Buggage RR, Tuaillon N. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. Ophthalmology 110(2):421-426, 2003.
11. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of primary intraocular lymphoma. Am J Ophthalmol 120(5):671-673, 1995.
12. Char DH, Ljung BM, Deschenes J, Miller TR. Intraocular lymphoma: immunological and cytological analysis. Br J Ophthalmol 72(12):905-911, 1988a.
13. Char DH, Ljung BM, Miller T, Phillips T. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 95:625-630, 1988b.
14. Char DH, Margolis L, Newman AB. Ocular reticulum cell sarcoma. Am J Ophthalmol 91(4):480-483, 1981.
15. Coupland SE, Chan CC, Smith J. Pathophysiology of retinal lymphoma. Ocul Immunol Inflamm 17(4):227-237, 2009.
16. Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol 242(11):901-913, 2004.
17. Davis JL. Intraocular lymphoma: a clinical perspective. Eye (Lond) 27(2):153-162, 2013.
18. Davis JL, Solomon D, Nussenblatt RB, Palestine AG, Chan CC. Immunocytochemical staining of vitreous cells. Indications, techniques, and results. Ophthalmology 99(2):250-256, 1992.
19. Davis JL, Viciana AL, Ruiz P. Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol 124(3):362-372, 1997.
20. Faia LJ, Chan CC. Primary intraocular lymphoma. Arch Pathol Lab Med 133(8):1228-1232, 2009.
21. Fardeau C, Lee CP, Merle-Béral H, Cassoux N, Bodaghi B, Davi F, Lehoang P. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin's primary intraocular lymphoma. Am J Ophthalmol 147(5):886-894, 894 e881, 2009.
22. Freeman LN, Schachat AP, Knox DL, Michels RG, Green WR. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 94:1631-1639, 1987.
23. Gallo EA, Mallory TB. Malignant lymphoma: a clinicopathological survey of 618 cases. Am J Pathol 18:381-429, 1942.
24. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 68(6):835-853, 1988.
25. Hong JT, Chae JB, Lee JY, Kim JG, Yoon YH. Ocular involvement in patients with primary CNS lymphoma. J Neurooncol 102(1):139-145, 2011.
26. Hormigo A, Abrey L, Heinemann MH, Deangelis LM. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br J Haematol 126(2):202-208, 2004.
27. Hormigo A, Deangelis LM. Primary intraocular lymphoma: Clinical features, diagnosis and treatment. Clin Lymphoma 4(1):22-29, 2003.
28. Ishida T, Ohno-Matsui K, Kaneko Y, Tobita H, Shimada N, Takase H, Mochizuki M. Fundus autofluorescence patterns in eyes with primary intraocular lymphoma. Retina 30(1):23-32, 2010.
29. Kimura K, Usui Y, Goto H. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol 56(4):383-389, 2012.
30. Kinoshita Y, Takasu K, Adachi Y, Yuri T, Nagumo S, Shikata N. Retrospective cytological study of intraocular lymphoma using vitreous and intraocular perfusion fluid. Diagn Cytopathol 40(7):604-607, 2012.
31. Levy-Clarke GA, Chan CC, Nussenblatt RB. Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am 19(4):739-749, 2005.
32. Mochizuki M, Singh AD. Epidemiology and clinical features of intraocular lymphoma. Ocul Immunol Inflamm 17(2):69-72, 2009.
33. Nasir S, Deangelis LM. Update on the management of primary CNS lymphoma. Oncology (Huntingt) 14(2):228-234; discussion 237-242, 244, 2000.
34. Pe'er J, Hochberg FH, Foster CS. Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm 17(5):299-306, 2009.
35. Peterson K, Gordon KB, Heinemann MH, Deangelis LM. The clinical spectrum of ocular lymphoma. Cancer 72(3):843-849, 1993.
36. Petersson M, Charo J, Salazar-Onfray F, Noffz G, Mohaupt M, Qin Z, Klein G, Blankenstein T, Kiessling R. Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1. J Immunol 161(5):2099-2105, 1998.
37. Prica A, Chan K, Cheung MC. Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis. Br J Haematol 158(5):600-607, 2012.
38. Qualman SL, Mendelsohn G, Mann RB, Green WR. Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer 52:878-886, 1983.
39. Rajagopal R, Harbour JW. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina 31(3):435-440, 2011.
40. Ramkumar HL, Shen De F, Tuo J, Braziel RM, Coupland SE, Smith JR, Chan CC. IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas. Graefes Arch Clin Exp Ophthalmol 250(10):1541-1548, 2012.
41. Rappaport H. Atlas of Tumor Pathology, Section III-Fascicle 8, Tumors of the Hematopoietic System. Armed Forces Institute of Pathology, Washington, D.C., USA, 1966.
42. Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre JY. Primary brain tumours in adults. Lancet 379(9830):1984-1996, 2012.
43. Rosenfeld MR, Pruitt AA. Management of malignant gliomas and primary CNS lymphoma: standard of care and future directions. Continuum (Minneap Minn) 18(2):406-415, 2012.
44. Sen HN, Bodaghi B, Hoang PL, Nussenblatt R. Primary intraocular lymphoma: diagnosis and differential diagnosis. Ocul Immunol Inflamm 17(3):133-141, 2009.
45. Sierra Del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Primary CNS lymphoma in immunocompetent patients. Oncologist 14(5):526-539, 2009.
46. Soussain C, Choquet S, Fourme E, Delgadillo D, Bouabdallah K, Ghesquieres H, Damaj G, Dupriez B, Vargaftig J, Gonzalez A, Houillier C, Taillandier L, Hoang-Xuan K, Leblond V. Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases. Haematologica 97(11):1751-1756, 2012.
47. Sugita S, Takase H, Sugamoto Y, Arai A, Miura O, Mochizuki M. Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid. Jpn J Ophthalmol 53(3):209-214, 2009.
48. Surawicz TS, Mccarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol 1(1):14-25, 1999.
49. Velez G, Chan CC, Csaky KG. Fluorescein angiographic findings in primary intraocular lymphoma. Retina 22(1):37-43, 2002.
50. Vogel MH, Font RL, Zimmerman LE, Levine RA. Reticulum cell sarcoma of the retina and uvea. Report of six cases and review of the literature. Am J Ophthalmol 66(2):205-215, 1968.
51. Whitcup SM, De Smet MD, Rubin BI, Palestine AG, Martin DF, Burnier MJ, Chan CC, Nussenblatt RB. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 100(9):1399-1406, 1993.
52. Whitcup SM, Stark-Vancs V, Wittes RE, Solomon D, Podgor MJ, Nussenblatt RB, Chan CC. Association of interleukin-10 in the vitreous and cerebral spinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 115:1157-1160, 1997.
53. White VA, Gascoyne RD, Paton KE. Use of the polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma. Arch Ophthalmol 117(6):761-765, 1999.
54. Zaldivar RA, Martin DF, Holden JT, Grossniklaus HE. Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology 111(9):1762-1767, 2004.
55. Wang Y, Shen D, Wang VM, Sen HN, Chan CC. Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma. Int J Mol Sci 12(9):5684-5697, 2011.